U.S. Markets close in 6 hrs 14 mins

Here's How P/E Ratios Can Help Us Understand Paragon Care Limited (ASX:PGC)

Simply Wall St

The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To keep it practical, we'll show how Paragon Care Limited's (ASX:PGC) P/E ratio could help you assess the value on offer. Paragon Care has a price to earnings ratio of 15.69, based on the last twelve months. That means that at current prices, buyers pay A$15.69 for every A$1 in trailing yearly profits.

See our latest analysis for Paragon Care

How Do I Calculate A Price To Earnings Ratio?

The formula for P/E is:

Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Or for Paragon Care:

P/E of 15.69 = AUD0.43 ÷ AUD0.03 (Based on the year to June 2019.)

Is A High P/E Ratio Good?

A higher P/E ratio implies that investors pay a higher price for the earning power of the business. That isn't a good or a bad thing on its own, but a high P/E means that buyers have a higher opinion of the business's prospects, relative to stocks with a lower P/E.

How Does Paragon Care's P/E Ratio Compare To Its Peers?

The P/E ratio indicates whether the market has higher or lower expectations of a company. The image below shows that Paragon Care has a lower P/E than the average (19.3) P/E for companies in the healthcare industry.

ASX:PGC Price Estimation Relative to Market, January 15th 2020

Paragon Care's P/E tells us that market participants think it will not fare as well as its peers in the same industry. Many investors like to buy stocks when the market is pessimistic about their prospects. You should delve deeper. I like to check if company insiders have been buying or selling.

How Growth Rates Impact P/E Ratios

Companies that shrink earnings per share quickly will rapidly decrease the 'E' in the equation. That means unless the share price falls, the P/E will increase in a few years. Then, a higher P/E might scare off shareholders, pushing the share price down.

Paragon Care shrunk earnings per share by 60% over the last year. But it has grown its earnings per share by 7.0% per year over the last five years. And it has shrunk its earnings per share by 21% per year over the last three years. This might lead to low expectations.

A Limitation: P/E Ratios Ignore Debt and Cash In The Bank

It's important to note that the P/E ratio considers the market capitalization, not the enterprise value. So it won't reflect the advantage of cash, or disadvantage of debt. Hypothetically, a company could reduce its future P/E ratio by spending its cash (or taking on debt) to achieve higher earnings.

While growth expenditure doesn't always pay off, the point is that it is a good option to have; but one that the P/E ratio ignores.

So What Does Paragon Care's Balance Sheet Tell Us?

Net debt is 44% of Paragon Care's market cap. You'd want to be aware of this fact, but it doesn't bother us.

The Bottom Line On Paragon Care's P/E Ratio

Paragon Care trades on a P/E ratio of 15.7, which is below the AU market average of 18.9. The debt levels are not a major concern, but the lack of EPS growth is likely weighing on sentiment.

Investors have an opportunity when market expectations about a stock are wrong. If it is underestimating a company, investors can make money by buying and holding the shares until the market corrects itself. So this free visualization of the analyst consensus on future earnings could help you make the right decision about whether to buy, sell, or hold.

You might be able to find a better buy than Paragon Care. If you want a selection of possible winners, check out this free list of interesting companies that trade on a P/E below 20 (but have proven they can grow earnings).

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.